Top Markets
Coin of the day
GeneDx Holdings Corp. GeneDx Holdings Corp.

GeneDx Holdings Corp.

WGS
Pozycja w akcjach #5445
GeneDx Holdings Corp. functions as a health intelligence firm singularly... GeneDx Holdings Corp. functions as a health intelligence firm singularly focused on the individual patient. It aims to revolutionize healthcare delivery by deploying advanced artificial intelligence and machine learning capabilities. These sophisticated algorithms are applied to vast, longitudinal clinical and genomic datasets to construct comprehensive, dynamic models of human health, ultimately defining personalized, optimal pathways for each person's well-being. Through its exclusive Centrellis health intelligence platform, the company gains profound insights into both disease states and overall wellness, enabling it to furnish evidence-based solutions for the most critical medical challenges. Eric Schadt established the corporation in October 2015, and its principal offices are located in Stamford, Connecticut.
Cena akcji
$90.29
Ostatnia synchronizacja: 2026-08-26
Kapitalizacja rynkowa
$2.69B
Zmiana (1 dzień)
3.30%
Zmiana (1 rok)
-30.11%
Kraj
US
Handel GeneDx Holdings Corp. (WGS)

Kategoria

Historia ceny akcji dla GeneDx Holdings Corp. (WGS)
Najwyższa cena zamknięcia: $80.79 dnia 2026-08-01

Najniższa cena zamknięcia: $329.40 dnia 2020-11-01
Historia cen akcji firmy GeneDx Holdings Corp. od 2020 do 2026
Roczna wydajność ceny akcji
Rok Wydajność
2026 (TTM) -35.49%
2025 91.72%
2024 3,422.67%
2023 -76.98%
2022 -94.30%
2021 -53.47%
2020 0.00%
Cena akcji podobnych firm lub konkurencji
Firma Cena akcji Zmiana 1r% Kraj
$73.43 -1.11%
US
$126.42 -36.52%
AU
$68.63 -6.29%
US
$61.08 155.24%
US
$30.49 0.00%
US